Qiongche Intelligence raised hundreds of millions of yuan to develop a "brain" for robots

# Qiongche Intelligence Raises Hundreds of Millions of Yuan to Create a "Brain" for Robots

Chinese company Qiongche Intelligence has closed its Series A funding round, raising several hundred million yuan to develop embodied AI technology — a field where language models transition from the virtual world into physical reality. Investments came from C Capital as lead investor, as well as from Sea Limited (the parent company of Shopee) and Prosperity7 Ventures, which believed in the startup's potential in earlier funding rounds and has now made an additional investment.

The startup occupies a unique niche at the intersection of several rapidly growing fields. While large language models like GPT or Claude exist on cloud servers and interact with users through text and voice, embodied AI is far more ambitious — it represents an attempt to give robots the ability to understand their surroundings, make independent decisions, and act physically. Qiongche Intelligence focuses on creating a universal "brain" that could work with different types of robotics, much like an operating system functions across devices from various manufacturers.

The company's key strategy is the development of foundation models with high generalization capability. This is critical for practical application. If you train a model only on data from a specific robot in a specific environment, it will act as a narrowly specialized tool. But Qiongche Intelligence aims for the opposite — to create a model that understands working principles and can adapt to new situations, types of equipment, and tasks without complete retraining. The collected investments will go toward this phase, where the company iterates on its models, expands datasets, and refines decision-making algorithms.

The entry of Sea Limited and other Asian investors signals regional interest in this technology. Southeast Asia is actively investing in robotics and automation, particularly in logistics and retail, where Sea Limited develops its platforms. For them, investing in Qiongche Intelligence is not just a financial bet, but also a way to gain access to technology that could potentially optimize their own operations.

The first commercial product the company plans to launch is quite specific — an intelligent pharmacy system. This is a logical choice: pharmacy services require working with product catalogs, rapid searching, sorting, and organization. Automating such processes could significantly reduce customer service time and minimize errors in medication selection. The launch of this solution is scheduled for the near future, which means the company is already close to commercializing its technology, rather than simply conducting fundamental research.

The significance of this funding extends beyond a single company. It signals that embodied AI is transitioning from an experimental phase to a phase of practical implementation. While Western companies like Boston Dynamics and Chinese leaders like Tesla Robotics focus on manufacturing robots themselves, companies like Qiongche Intelligence work on a platform that could make any robot smarter. This is a much more scalable model, capable of accelerating the adoption of automation across the industry.